Study of AEB071 (a Protein Kinase C Inhibitor) in Patients With CD79-mutant Diffuse Large B-Cell Lymphoma

Memorial Sloan Kettering Cancer Center MSK 2, New York

Novartis Investigative Site, Taipei

Novartis Investigative Site, Torino

Novartis Investigative Site, Berlin

Novartis Investigative Site, Milan

Ohio State Comprehensive Cancer Center/James Cancer Hospital Ohio State, Columbus

Washington University School of Medicine Div. of Medical Oncology, St Louis

Novartis Investigative Site, Rouen

Novartis Investigative Site, München

Novartis Investigative Site, Créteil

City of Hope National Medical Center, Duarte

Hackensack University Medical Center Hackensack (SC), Hackensack

University of Texas/MD Anderson Cancer Center SC Location, Houston

Novartis Investigative Site, Lille

Novartis Investigative Site, Pierre-Benite Cédex

Novartis Investigative Site, Shatin, New Territories

Novartis Investigative Site, Amsterdam

Novartis Investigative Site, Groningen

Novartis Investigative Site, Rotterdam

Novartis Investigative Site, Rotterdam

Novartis Investigative Site, Seoul

Novartis Investigative Site, Barcelona

Novartis Investigative Site, Barcelona

Novartis Investigative Site, Manchester